Espoo, Finland

Päivi Hietanen

This inventor holds 1 USPTO granted patent. Top assignee: Orion Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Päivi Hietanen. Retrieved from https://idiyas.com/inventor/pandaumlivi-hietanen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Päivi Hietanen: Innovator in Medical Applications

Introduction

Päivi Hietanen is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of medicine, particularly in the area of endothelin-mediated diseases. His innovative work has led to the development of a unique medical application that holds promise for improving health outcomes.

Latest Patents

Hietanen holds a patent for an "Agent for lowering endothelin levels." This invention relates to the medical use of the triphenylethylene antiestrogen toremifene, or a pharmaceutically acceptable derivative thereof, for lowering endothelin-1 levels in mammals. This application is particularly relevant for the prevention or treatment of diseases mediated by endothelin.

Career Highlights

Päivi Hietanen is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to focus on groundbreaking research and development in medical applications. His contributions have been instrumental in advancing the understanding and treatment of endothelin-related conditions.

Collaborations

Hietanen has collaborated with esteemed colleagues such as Olavi Ylikorkala and Merja Metsä-Heikkilä. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Päivi Hietanen's work exemplifies the impact of innovative thinking in medicine. His patent for lowering endothelin levels showcases his commitment to advancing healthcare solutions. Through his career at Orion Corporation and collaborations with other experts, he continues to contribute to significant medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…